Cassava Sciences | L'Utile Operativo



Operating Profit Cambiamento Data
Abbott USD 2.07B 415M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Biogen USD 851.8M 540.6M 2025-06
Cassava Sciences USD -29487000 1.14M 2024-12
Eisai JPY 20.74B 21.77B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Geron USD -12454000 4.25M 2025-06
J&J USD 6.94B 6.69B 2025-06
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12


Cassava Sciences L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.